Letter to Editor re: Varicose Vein Stripping vs Haemodynamic Correction (CHIVA): a Long Term Randomised Trial. by S. Carandina, C. Mari, M. De Palma, M.G. Marcellino, C. Cisno, A. Legnaro, A. Liboni and P. Zamboni, in Eur J Vasc Endovasc Surg 2008;35:230–7.  by Ricci, S.
CORRESPONDENCE
Regarding: Efficacy of Viabahn in the Treatment of
Severe Superficial Femoral Artery Lesions: Which
Factors Influence Long-term Patency?
Following the paper of Alimi et al.,1 we would like to com-
ment on the anatomic properties of the SFA. Schillinger
et al.,2 compared PTA, with and without stenting, and at
twelve months the rate of restenosis was 37% in the stent
group and 63% in the angioplasty only group. These results
in favour of angioplasty alone are presumably related to the
special anatomy of the SFA and the inferior performance of
stents when regularly exposed to wall stress, torsion and
flexion. In claudicants with lesions shorter than 15 cm,
stenting leads to larger luminal vessel diameter peri-proce-
durally. Katzen, at the Veith-Symposium 2007, reported
that primary patency after 12 months was 80% in the
stented group versus 38% in PTA alone group. Particularly
for the distal SFA high stent flexibility is mandatory. Calci-
fied lesions may require stents with higher radial forces
than non-calcified long lesions. On the other hand, covered
stents as used in the Alimi study may have distinct advan-
tages such as prevention of intimal ingrowth compared to
either PTA only or bare metal stents. However, it has
been shown that intimal hyperplasia was not prevented
completely but was limited to the border of the stented
area. Of course, careful duplex follow-up is mandatory.
Finally, the study is a fine example of the benefit of
combining stenting with conventional vascular surgical
procedures and illustrates the necessity of training vascular
surgeons in endovascular techniques.
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To Editor,
I enjoyed very much the paper: Varicose Vein Stripping vs
Haemodynamic Correction (CHIVA): a Long Term Rando-
mised Trial. by S. Carandina, C. Mari, M. De Palma, M.G.
Marcellino, C. Cisno, A. Legnaro, A. Liboni and P. Zamboni,
in Eur J Vasc Endovasc Surg 2008;35:230e7.
It is well designed and is possibly a milestone of varicose
veins treatment results analysis. It demonstrates that
varicose veins Haemodynamic Correction (CHIVA) may be
considered already a valid solution and, in any case, cannot
be ignored.
I am amazed for the low incidence of recurrences not
only for CHIVA treated patents but also for those treated byDOI of original article: 10.1016/j.ejvs.2007.09.011.
1. High ligation is the major risk factor of recurrences in
open surgery for varicose veins.1
2. About 50% of varicose patients presents with a compe-
tent terminal valve of the sapheno-femoral junction
(SFJ).2 In contrast to what stated by Dr. Ricci, this rep-
resents the best haemodynamic presentation for CHIVA
because can be treated without the need of high tie,
and in a single shot, by flush ligation and avulsion of
the insufficient tributaries from the saphenous trunk.3
To the contrary standard stripping always requires
high ligation so increasing the risk of recurrences from
the junction.1
3. In our study we decided to randomize patients with the
same haemodynamic presentation, and with the need
in both groups of treating the SFJ, because the random-
ization of the whole varicose patients would have in-
creased the stripping group risk of recurrence. Such
a presentation corresponds to about 30e35% of the
whole varicose patients.4
4. Nowadays, double session in CHIVA is required only for
incompetent terminal valve in the absence of a re-entry
perforator located on the trunk. However, saphenous
segmental angioplasty or valvulotomy can be adopted
to favour the re-entry through a distal perforator cen-
tred on the trunk, so avoiding the need of a second
session.4
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P. Zamboni*
Correspondence 119Stripping. However, even if none evidenced, an important
selection in patients inclusion was done: only cases with
‘‘At least one re-entry perforator located on the saphenous
trunk’’, were included. As we know, these are the most
favourable cases to be treated with the haemodynamic
procedure. Moreover, this selection is not declared in the
text but only in table 1; in the same table exclusion of the
cases without ‘‘At least one re-entry perforator located on
the saphenous trunk’’ (50e60% of varicose patients accord-
ing to the leading Author)1 is not underlined.
I wonder what could be the results of this study if
Authors included all the cases without any selection:
theoretically the Stripping results would be the same,
unlike Haemodynamic Correction results, that would find
in that excluded group of patients a less favourable
situation. Furthermore, these cases could not be operated
by Haemodynamic Correction in a single session, but would
require one or more successive procedures in a non pre-
dictable moment. Finally, 10% of these same cases are not
available for creating a draining system (the purpose of
Haemodynamic Correction) and have consequently a higher
probability of developing a saphenous thrombosis.
Thank you for the attention.
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Dear Dr. Ricci,
Thank you for your letter giving us the possibility of
clarifying the followings.
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